Background: We examined the levels of long non-coding RNAs (lncRNAs) in the plasma of
patients with gastric cancer to assess their clinical significance for diseases diagnosing and …

Background We previously demonstrated the potential of circulating tumor DNA (ctDNA) for
the amplification of detecting HER2 in patients with gastric cancer (GC). In the present study, …

Background: This study aims to explore novel microRNAs in plasma for screening cancer
and predicting clinical outcomes in pancreatic cancer (PCa) patients using a microRNA array-…

MicroRNAs have been reported to be stably detectable in plasma/serum and to exhibit resistance
to endogenous ribonuclease activity because of binding to proteins such as Argonaute-…

Patients with gastric cancer are often malnourished during tumor progression. Malnutrition
is a risk factor for postoperative complications and a poor prognosis. Early evaluation and …

Background Recently, circulating microRNAs have been reported to be stably detectable in
plasma/serum and to function as potent non-invasive biomarkers in various cancers. We …

Hepatocellular carcinoma (HCC), with its high incidence and mortality rate, is one of the
most common malignant tumors. Despite recent development of a diagnostic and treatment …

MicroRNAs (miRNAs) are short noncoding RNAs that post-transcriptionally regulate gene
expression and play important roles in various physiological and developmental processes …

AIM: To determine the best cut-off value between the early and late recurrence periods after
the initial recurrence of hepatocellular carcinoma (HCC). METHODS: The clinical records of …

Background: MicroRNAs (miRNAs) such as miR-17-5p, miR-21, miR-106a and miR-106b
are reported to be highly expressed in gastric carcinoma (GC) tissues. Recently, we reported …